Prospective Study of Hydroxocobalamin for Acute Cyanide Poisoning in Smoke Inhalation
Open Access
- 30 June 2007
- journal article
- clinical trial
- Published by Elsevier BV in Annals of Emergency Medicine
- Vol. 49 (6), 794-801.e2
- https://doi.org/10.1016/j.annemergmed.2007.01.026
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Focus on Smoke Inhalation—The Most Common Cause of Acute Cyanide PoisoningPrehospital and Disaster Medicine, 2006
- Prehospital Administration of Hydroxocobalamin for Smoke Inhalation-Associated Cyanide Poisoning: 8 Years of Experience in the Paris Fire BrigadeClinical Toxicology, 2006
- Life-Threatening Interaction Between Complementary Medicines: Cyanide Toxicity Following Ingestion of Amygdalin and Vitamin CAnnals of Pharmacotherapy, 2005
- Elevated plasma cyanide level after hydroxocobalamin infusion for cyanide poisoningThe American Journal of Emergency Medicine, 2004
- Cyanide Poisoning and Its TreatmentPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2004
- Toxicity of Fire SmokeCritical Reviews in Toxicology, 2002
- Hydroxocobalamin: Improved public health readiness for cyanide disastersAnnals of Emergency Medicine, 2001
- Elevated Blood Cyanide Concentrations in Victims of Smoke InhalationNew England Journal of Medicine, 1991
- Toxic smoke inhalation: Cyanide poisoning in fire victimsThe American Journal of Emergency Medicine, 1987
- Cyanide poisoning from propionitrile exposureThe Journal of Emergency Medicine, 1987